Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 11 | 2024 | 1275 | 2.220 |
Why?
|
Lower Extremity | 14 | 2023 | 1201 | 1.630 |
Why?
|
American Heart Association | 11 | 2024 | 1043 | 1.510 |
Why?
|
Advisory Committees | 6 | 2017 | 788 | 1.040 |
Why?
|
Progeria | 7 | 2023 | 188 | 0.990 |
Why?
|
Vasodilation | 20 | 2009 | 966 | 0.980 |
Why?
|
Cardiology | 10 | 2024 | 1693 | 0.930 |
Why?
|
Peripheral Vascular Diseases | 10 | 2017 | 488 | 0.920 |
Why?
|
Brachial Artery | 16 | 2009 | 366 | 0.860 |
Why?
|
Ultrasonography, Doppler | 8 | 2020 | 462 | 0.740 |
Why?
|
Ankle Brachial Index | 3 | 2018 | 163 | 0.710 |
Why?
|
Arteries | 5 | 2020 | 1121 | 0.700 |
Why?
|
Disease Management | 5 | 2021 | 2507 | 0.680 |
Why?
|
Pulmonary Embolism | 7 | 2023 | 2571 | 0.650 |
Why?
|
Societies, Medical | 11 | 2018 | 3923 | 0.630 |
Why?
|
Nitroglycerin | 8 | 2016 | 330 | 0.600 |
Why?
|
Practice Guidelines as Topic | 9 | 2016 | 7400 | 0.600 |
Why?
|
Thromboembolism | 4 | 2016 | 992 | 0.550 |
Why?
|
Perioperative Care | 6 | 2024 | 1037 | 0.540 |
Why?
|
Endothelium, Vascular | 16 | 2009 | 4420 | 0.530 |
Why?
|
Vascular Diseases | 5 | 2020 | 1160 | 0.460 |
Why?
|
Takayasu Arteritis | 1 | 2015 | 105 | 0.450 |
Why?
|
Carotid Arteries | 9 | 2017 | 941 | 0.440 |
Why?
|
Arteriosclerosis | 7 | 2004 | 1056 | 0.440 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2014 | 109 | 0.430 |
Why?
|
Angina Pectoris | 1 | 2016 | 959 | 0.410 |
Why?
|
Arterial Occlusive Diseases | 5 | 2008 | 749 | 0.380 |
Why?
|
Carotid Stenosis | 6 | 2016 | 859 | 0.380 |
Why?
|
Exercise Tolerance | 1 | 2016 | 838 | 0.380 |
Why?
|
Pulmonary Artery | 3 | 2016 | 1929 | 0.370 |
Why?
|
Peroneal Neuropathies | 1 | 2010 | 22 | 0.360 |
Why?
|
Stroke Volume | 1 | 2024 | 5521 | 0.350 |
Why?
|
Giant Cell Arteritis | 3 | 2020 | 307 | 0.350 |
Why?
|
Intermittent Claudication | 4 | 2017 | 304 | 0.340 |
Why?
|
Regional Blood Flow | 8 | 2009 | 1498 | 0.330 |
Why?
|
Ankle | 2 | 2019 | 350 | 0.330 |
Why?
|
Angiography | 7 | 2020 | 1597 | 0.320 |
Why?
|
Estrogen Replacement Therapy | 5 | 2000 | 1208 | 0.310 |
Why?
|
Diagnostic Imaging | 8 | 2018 | 3534 | 0.310 |
Why?
|
Venous Thromboembolism | 5 | 2024 | 1869 | 0.300 |
Why?
|
Leg | 6 | 2020 | 1087 | 0.300 |
Why?
|
Carotid Artery Diseases | 3 | 2011 | 877 | 0.290 |
Why?
|
Femoral Artery | 4 | 2011 | 826 | 0.280 |
Why?
|
Cardiovascular Diseases | 13 | 2024 | 15520 | 0.280 |
Why?
|
Mental Processes | 1 | 2008 | 244 | 0.280 |
Why?
|
Radial Artery | 1 | 2008 | 187 | 0.270 |
Why?
|
Blood Vessels | 2 | 2006 | 1111 | 0.270 |
Why?
|
Temporal Arteries | 2 | 2017 | 155 | 0.270 |
Why?
|
Veins | 4 | 2020 | 767 | 0.270 |
Why?
|
Ultrasonography, Interventional | 6 | 2017 | 1496 | 0.260 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 1457 | 0.260 |
Why?
|
Aortic Diseases | 3 | 2014 | 735 | 0.250 |
Why?
|
Pulsatile Flow | 4 | 2012 | 320 | 0.250 |
Why?
|
Oscillometry | 1 | 2005 | 150 | 0.250 |
Why?
|
Humans | 122 | 2024 | 761208 | 0.250 |
Why?
|
Embolism, Cholesterol | 1 | 2004 | 32 | 0.230 |
Why?
|
Insurance Benefits | 2 | 2016 | 186 | 0.220 |
Why?
|
Aneurysm, False | 2 | 2006 | 255 | 0.220 |
Why?
|
Magnetic Resonance Angiography | 8 | 2020 | 1432 | 0.220 |
Why?
|
Saphenous Vein | 4 | 2009 | 516 | 0.220 |
Why?
|
Blood Pressure | 10 | 2018 | 8479 | 0.210 |
Why?
|
Foot Diseases | 1 | 2004 | 148 | 0.210 |
Why?
|
Ischemia | 4 | 2023 | 1889 | 0.200 |
Why?
|
Exercise | 2 | 2019 | 5874 | 0.200 |
Why?
|
Iliac Artery | 2 | 2020 | 343 | 0.200 |
Why?
|
Heart Failure | 2 | 2024 | 11701 | 0.200 |
Why?
|
Thoracic Outlet Syndrome | 2 | 2015 | 97 | 0.200 |
Why?
|
Stents | 5 | 2016 | 3177 | 0.200 |
Why?
|
Blood Pressure Determination | 1 | 2005 | 633 | 0.190 |
Why?
|
Endarterectomy, Carotid | 3 | 2016 | 554 | 0.190 |
Why?
|
Heart Ventricles | 1 | 2014 | 3813 | 0.190 |
Why?
|
United States | 29 | 2024 | 72339 | 0.190 |
Why?
|
Vasomotor System | 2 | 1999 | 208 | 0.190 |
Why?
|
Aortic Aneurysm, Abdominal | 4 | 2018 | 1228 | 0.180 |
Why?
|
Estradiol | 4 | 2008 | 1937 | 0.180 |
Why?
|
Aortography | 2 | 2020 | 421 | 0.180 |
Why?
|
Geriatric Assessment | 1 | 2008 | 1409 | 0.180 |
Why?
|
Aged | 43 | 2023 | 169288 | 0.180 |
Why?
|
Retinal Artery Occlusion | 1 | 2021 | 77 | 0.180 |
Why?
|
Vascular Patency | 5 | 2010 | 911 | 0.180 |
Why?
|
Coronary Vessels | 5 | 2016 | 3111 | 0.180 |
Why?
|
Retinal Artery | 1 | 2021 | 109 | 0.180 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2024 | 432 | 0.170 |
Why?
|
Ultrasonography | 12 | 2014 | 5969 | 0.170 |
Why?
|
Gangrene | 3 | 2023 | 91 | 0.170 |
Why?
|
Aortitis | 1 | 2020 | 76 | 0.170 |
Why?
|
Female | 71 | 2023 | 392544 | 0.170 |
Why?
|
Radiology | 5 | 2017 | 2112 | 0.170 |
Why?
|
Venous Insufficiency | 2 | 2011 | 108 | 0.170 |
Why?
|
Male | 62 | 2023 | 360693 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 6 | 2015 | 20588 | 0.160 |
Why?
|
Popliteal Artery | 3 | 2009 | 310 | 0.160 |
Why?
|
Predictive Value of Tests | 13 | 2020 | 15308 | 0.160 |
Why?
|
Thrombin | 1 | 2001 | 593 | 0.160 |
Why?
|
Venous Thrombosis | 3 | 2020 | 1304 | 0.160 |
Why?
|
Hemostatics | 1 | 2001 | 240 | 0.160 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6341 | 0.160 |
Why?
|
Ventricular Function, Left | 2 | 2024 | 3899 | 0.150 |
Why?
|
Prognosis | 9 | 2024 | 29687 | 0.150 |
Why?
|
Progesterone | 2 | 1999 | 742 | 0.140 |
Why?
|
Medicare | 8 | 2023 | 6773 | 0.140 |
Why?
|
Aging | 3 | 2011 | 8702 | 0.140 |
Why?
|
Middle Aged | 41 | 2020 | 220853 | 0.140 |
Why?
|
Angiography, Digital Subtraction | 2 | 2017 | 335 | 0.140 |
Why?
|
Ultrasonography, Doppler, Duplex | 7 | 2012 | 198 | 0.140 |
Why?
|
Coronary Artery Disease | 5 | 2016 | 6505 | 0.140 |
Why?
|
Risk Factors | 22 | 2024 | 74239 | 0.140 |
Why?
|
Inflammation Mediators | 1 | 2005 | 1885 | 0.140 |
Why?
|
Evidence-Based Medicine | 7 | 2018 | 3691 | 0.130 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2009 | 2157 | 0.130 |
Why?
|
Treatment Outcome | 22 | 2023 | 64681 | 0.130 |
Why?
|
Quality of Life | 2 | 2019 | 13367 | 0.130 |
Why?
|
Piperidines | 2 | 2016 | 1656 | 0.130 |
Why?
|
Aortic Aneurysm | 1 | 2020 | 648 | 0.130 |
Why?
|
Exercise Test | 2 | 2018 | 2165 | 0.130 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 99 | 0.130 |
Why?
|
Hypothermia | 1 | 2017 | 188 | 0.120 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 825 | 0.120 |
Why?
|
Consensus | 4 | 2020 | 3134 | 0.120 |
Why?
|
Verapamil | 1 | 2015 | 242 | 0.120 |
Why?
|
Mentors | 1 | 2020 | 663 | 0.120 |
Why?
|
Vitamin E | 1 | 1999 | 872 | 0.120 |
Why?
|
Coronary Stenosis | 2 | 2017 | 802 | 0.120 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1097 | 0.120 |
Why?
|
Fontan Procedure | 2 | 2011 | 796 | 0.120 |
Why?
|
Pulse | 3 | 2017 | 218 | 0.120 |
Why?
|
Pravastatin | 1 | 2016 | 392 | 0.120 |
Why?
|
Pain | 3 | 2017 | 5072 | 0.110 |
Why?
|
Cognition Disorders | 1 | 2008 | 3976 | 0.110 |
Why?
|
Coronary Thrombosis | 1 | 2016 | 440 | 0.110 |
Why?
|
Transplantation Immunology | 1 | 2015 | 537 | 0.110 |
Why?
|
Estrogens | 3 | 2000 | 1522 | 0.110 |
Why?
|
Rest | 1 | 2018 | 920 | 0.110 |
Why?
|
Whole Body Imaging | 1 | 2015 | 282 | 0.110 |
Why?
|
Facial Transplantation | 1 | 2015 | 222 | 0.110 |
Why?
|
Anesthesia, Obstetrical | 1 | 2015 | 232 | 0.110 |
Why?
|
Oxygen | 1 | 2024 | 4227 | 0.110 |
Why?
|
Arm | 2 | 2008 | 589 | 0.100 |
Why?
|
Vascular Resistance | 1 | 1996 | 933 | 0.100 |
Why?
|
Arteriovenous Fistula | 1 | 2016 | 319 | 0.100 |
Why?
|
Farnesyltranstransferase | 1 | 2012 | 71 | 0.100 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2012 | 26 | 0.100 |
Why?
|
Patient Care Planning | 1 | 2018 | 901 | 0.100 |
Why?
|
Pyridines | 2 | 2016 | 2872 | 0.100 |
Why?
|
Acute Disease | 5 | 2017 | 7226 | 0.100 |
Why?
|
Health Services Misuse | 1 | 2014 | 244 | 0.100 |
Why?
|
Heart Defects, Congenital | 3 | 2023 | 4673 | 0.100 |
Why?
|
Insulin Resistance | 4 | 2007 | 3952 | 0.100 |
Why?
|
Adult | 31 | 2020 | 221119 | 0.100 |
Why?
|
Exercise Therapy | 1 | 2019 | 922 | 0.100 |
Why?
|
Ventricular Function, Right | 1 | 2016 | 618 | 0.100 |
Why?
|
Syncope | 1 | 2014 | 428 | 0.090 |
Why?
|
Diphosphonates | 1 | 2016 | 634 | 0.090 |
Why?
|
Atherosclerosis | 4 | 2010 | 3406 | 0.090 |
Why?
|
Glucocorticoids | 2 | 2017 | 2159 | 0.090 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2015 | 774 | 0.090 |
Why?
|
Patient Care Management | 1 | 2014 | 303 | 0.090 |
Why?
|
Myocardium | 2 | 2018 | 4746 | 0.090 |
Why?
|
Nitric Oxide | 6 | 2009 | 2136 | 0.090 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 513 | 0.090 |
Why?
|
Aorta, Abdominal | 2 | 2012 | 625 | 0.090 |
Why?
|
Myocardial Contraction | 1 | 2016 | 1516 | 0.090 |
Why?
|
Stockings, Compression | 1 | 2010 | 36 | 0.090 |
Why?
|
Anticoagulants | 4 | 2009 | 4795 | 0.090 |
Why?
|
Pulmonary Veins | 1 | 2016 | 743 | 0.090 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2016 | 629 | 0.090 |
Why?
|
Imidazoles | 1 | 2016 | 1172 | 0.090 |
Why?
|
Myocardial Infarction | 4 | 2016 | 11476 | 0.090 |
Why?
|
Blood Flow Velocity | 2 | 2011 | 1375 | 0.090 |
Why?
|
Hypesthesia | 1 | 2010 | 106 | 0.090 |
Why?
|
Postoperative Care | 1 | 2016 | 1468 | 0.090 |
Why?
|
Forearm | 3 | 1997 | 427 | 0.080 |
Why?
|
Vascular Surgical Procedures | 2 | 2010 | 1489 | 0.080 |
Why?
|
Retrospective Studies | 13 | 2023 | 80674 | 0.080 |
Why?
|
Thoracic Injuries | 1 | 2012 | 289 | 0.080 |
Why?
|
Postmenopause | 3 | 2008 | 2514 | 0.080 |
Why?
|
Stroke | 3 | 2016 | 9721 | 0.080 |
Why?
|
Surgical Procedures, Operative | 4 | 2024 | 1923 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2004 | 1488 | 0.080 |
Why?
|
Risk Assessment | 4 | 2024 | 24021 | 0.080 |
Why?
|
Enoxaparin | 2 | 2009 | 391 | 0.080 |
Why?
|
Heart | 2 | 2018 | 4431 | 0.080 |
Why?
|
Enzyme Inhibitors | 5 | 2012 | 3702 | 0.080 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2015 | 385 | 0.080 |
Why?
|
Prospective Studies | 14 | 2023 | 54435 | 0.080 |
Why?
|
Tropomyosin | 2 | 1985 | 104 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14675 | 0.070 |
Why?
|
Echocardiography | 3 | 2018 | 5006 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 2 | 2012 | 4052 | 0.070 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2015 | 1425 | 0.070 |
Why?
|
Hydrochlorothiazide | 1 | 2007 | 94 | 0.070 |
Why?
|
Hyperemia | 5 | 2009 | 225 | 0.070 |
Why?
|
Cardiovascular System | 1 | 2014 | 836 | 0.070 |
Why?
|
Wrist | 1 | 2008 | 226 | 0.070 |
Why?
|
Graft Occlusion, Vascular | 1 | 2010 | 537 | 0.070 |
Why?
|
Manometry | 1 | 2009 | 453 | 0.070 |
Why?
|
Plethysmography | 1 | 2006 | 174 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2015 | 1305 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2944 | 0.070 |
Why?
|
Pain Measurement | 1 | 2016 | 3549 | 0.070 |
Why?
|
Radiography, Interventional | 1 | 2013 | 1122 | 0.070 |
Why?
|
Posture | 1 | 2010 | 956 | 0.070 |
Why?
|
Tetralogy of Fallot | 1 | 2011 | 618 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8519 | 0.060 |
Why?
|
Aorta, Thoracic | 1 | 2012 | 1096 | 0.060 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2006 | 232 | 0.060 |
Why?
|
Wounds, Nonpenetrating | 1 | 2012 | 808 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3418 | 0.060 |
Why?
|
Principal Component Analysis | 1 | 2008 | 942 | 0.060 |
Why?
|
Likelihood Functions | 1 | 2008 | 991 | 0.060 |
Why?
|
Renal Artery | 1 | 2006 | 351 | 0.060 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 431 | 0.060 |
Why?
|
Blood Volume | 1 | 2006 | 547 | 0.060 |
Why?
|
Drug Therapy, Combination | 4 | 2016 | 6304 | 0.060 |
Why?
|
Peptides | 1 | 2016 | 4353 | 0.060 |
Why?
|
Renin-Angiotensin System | 2 | 2007 | 735 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8457 | 0.060 |
Why?
|
Hypertension | 2 | 2018 | 8536 | 0.060 |
Why?
|
Diuretics | 1 | 2007 | 611 | 0.060 |
Why?
|
Polysaccharides | 2 | 2007 | 1014 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10218 | 0.060 |
Why?
|
C-Reactive Protein | 3 | 2020 | 3821 | 0.060 |
Why?
|
Chronic Disease | 2 | 2016 | 9319 | 0.060 |
Why?
|
Spironolactone | 1 | 2007 | 412 | 0.050 |
Why?
|
Contrast Media | 3 | 2012 | 5311 | 0.050 |
Why?
|
Bioreactors | 1 | 2024 | 246 | 0.050 |
Why?
|
Accreditation | 1 | 2006 | 473 | 0.050 |
Why?
|
Pericardial Effusion | 1 | 2005 | 247 | 0.050 |
Why?
|
Automation | 1 | 2005 | 585 | 0.050 |
Why?
|
Sex Characteristics | 3 | 2023 | 2640 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1555 | 0.050 |
Why?
|
Adolescent | 10 | 2018 | 88298 | 0.050 |
Why?
|
Fingers | 1 | 2006 | 506 | 0.050 |
Why?
|
Thiazolidinediones | 1 | 2006 | 460 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 691 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3051 | 0.050 |
Why?
|
Hand | 1 | 2008 | 902 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20119 | 0.050 |
Why?
|
General Surgery | 1 | 2014 | 1693 | 0.050 |
Why?
|
Cacao | 1 | 2003 | 98 | 0.050 |
Why?
|
Biphenyl Compounds | 1 | 2008 | 1007 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3215 | 0.050 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2007 | 376 | 0.050 |
Why?
|
Coronary Circulation | 2 | 2007 | 1611 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4481 | 0.050 |
Why?
|
Aged, 80 and over | 9 | 2016 | 58952 | 0.050 |
Why?
|
Endovascular Procedures | 1 | 2016 | 2181 | 0.050 |
Why?
|
Acetylcholine | 3 | 1999 | 629 | 0.050 |
Why?
|
Follow-Up Studies | 8 | 2016 | 39126 | 0.050 |
Why?
|
Insulin | 5 | 2008 | 6588 | 0.050 |
Why?
|
Tetrazoles | 1 | 2008 | 909 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15841 | 0.050 |
Why?
|
District of Columbia | 1 | 2001 | 159 | 0.050 |
Why?
|
Outpatients | 2 | 2009 | 1598 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2015 | 6585 | 0.050 |
Why?
|
Aortic Valve Stenosis | 1 | 2013 | 2018 | 0.050 |
Why?
|
Washington | 1 | 2001 | 314 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2003 | 524 | 0.050 |
Why?
|
Coronary Disease | 3 | 2004 | 5921 | 0.050 |
Why?
|
Survival Analysis | 3 | 2015 | 10088 | 0.050 |
Why?
|
Progestins | 2 | 2000 | 301 | 0.040 |
Why?
|
Vena Cava, Inferior | 1 | 2024 | 459 | 0.040 |
Why?
|
Flavonoids | 1 | 2003 | 444 | 0.040 |
Why?
|
Pennsylvania | 1 | 2001 | 612 | 0.040 |
Why?
|
Child, Preschool | 5 | 2018 | 42224 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2007 | 973 | 0.040 |
Why?
|
Limb Salvage | 1 | 2023 | 480 | 0.040 |
Why?
|
Electrocardiography | 3 | 2018 | 6387 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 12976 | 0.040 |
Why?
|
Secondary Prevention | 2 | 2021 | 1472 | 0.040 |
Why?
|
Observer Variation | 3 | 2015 | 2610 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 527 | 0.040 |
Why?
|
Hemodynamics | 2 | 2008 | 4165 | 0.040 |
Why?
|
Foot | 1 | 2023 | 575 | 0.040 |
Why?
|
Vasodilator Agents | 4 | 2009 | 989 | 0.040 |
Why?
|
Injections | 1 | 2001 | 832 | 0.040 |
Why?
|
Coronary Artery Bypass | 2 | 2017 | 2193 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 8998 | 0.040 |
Why?
|
Beverages | 1 | 2003 | 821 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2012 | 3366 | 0.040 |
Why?
|
Craniotomy | 1 | 2002 | 741 | 0.040 |
Why?
|
Antihypertensive Agents | 1 | 2008 | 2019 | 0.040 |
Why?
|
Heart Murmurs | 1 | 2018 | 92 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 782 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 1 | 2004 | 1086 | 0.040 |
Why?
|
Warfarin | 1 | 2006 | 1482 | 0.040 |
Why?
|
Cross-Over Studies | 2 | 2007 | 2082 | 0.040 |
Why?
|
Neoplasms | 2 | 2023 | 22140 | 0.040 |
Why?
|
Fertilization | 1 | 2018 | 198 | 0.040 |
Why?
|
Homocystine | 1 | 1997 | 21 | 0.040 |
Why?
|
Stress, Mechanical | 2 | 2016 | 1674 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4584 | 0.040 |
Why?
|
Blood Platelets | 2 | 1985 | 2477 | 0.040 |
Why?
|
Monitoring, Physiologic | 2 | 2015 | 1780 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1651 | 0.040 |
Why?
|
Subclavian Artery | 1 | 2017 | 133 | 0.040 |
Why?
|
Time Factors | 6 | 2016 | 39957 | 0.040 |
Why?
|
Adipose Tissue | 2 | 2006 | 3313 | 0.030 |
Why?
|
Wound Healing | 1 | 2008 | 2800 | 0.030 |
Why?
|
Drug Administration Schedule | 3 | 2012 | 4851 | 0.030 |
Why?
|
Sex Factors | 3 | 2020 | 10553 | 0.030 |
Why?
|
Protein Prenylation | 1 | 2016 | 70 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2017 | 386 | 0.030 |
Why?
|
Cohort Studies | 7 | 2015 | 41496 | 0.030 |
Why?
|
Aneurysm | 1 | 1999 | 337 | 0.030 |
Why?
|
Triglycerides | 2 | 2004 | 2457 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2012 | 10756 | 0.030 |
Why?
|
Biopsy | 2 | 2017 | 6781 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2005 | 3210 | 0.030 |
Why?
|
Anastomosis, Surgical | 3 | 2008 | 982 | 0.030 |
Why?
|
Thrombectomy | 1 | 2020 | 703 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2008 | 7046 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1162 | 0.030 |
Why?
|
Inflammation | 2 | 2020 | 10759 | 0.030 |
Why?
|
Carrier Proteins | 2 | 1985 | 4935 | 0.030 |
Why?
|
Cholesterol | 3 | 1999 | 2902 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3271 | 0.030 |
Why?
|
omega-N-Methylarginine | 2 | 2009 | 108 | 0.030 |
Why?
|
Emergencies | 1 | 2021 | 1217 | 0.030 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2006 | 260 | 0.030 |
Why?
|
Reference Values | 4 | 2007 | 4921 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2006 | 2374 | 0.030 |
Why?
|
Peripartum Period | 1 | 2015 | 137 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2003 | 1893 | 0.030 |
Why?
|
Age Factors | 4 | 2015 | 18384 | 0.030 |
Why?
|
Program Development | 1 | 2020 | 1294 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2005 | 4340 | 0.030 |
Why?
|
Boston | 2 | 2010 | 9327 | 0.030 |
Why?
|
Triage | 1 | 2021 | 985 | 0.030 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2018 | 497 | 0.030 |
Why?
|
Child | 5 | 2018 | 80152 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1086 | 0.030 |
Why?
|
Homocysteine | 1 | 1997 | 637 | 0.030 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2016 | 578 | 0.030 |
Why?
|
Aorta | 1 | 2021 | 2040 | 0.030 |
Why?
|
Professional Practice | 1 | 2015 | 313 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2195 | 0.030 |
Why?
|
Tunica Intima | 1 | 2015 | 458 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2006 | 3089 | 0.030 |
Why?
|
Anesthesia, Epidural | 1 | 2015 | 233 | 0.030 |
Why?
|
Registries | 2 | 2022 | 8247 | 0.030 |
Why?
|
Elasticity | 2 | 2006 | 655 | 0.030 |
Why?
|
Curriculum | 1 | 2006 | 3741 | 0.030 |
Why?
|
Prednisone | 1 | 2017 | 1565 | 0.030 |
Why?
|
Potassium | 2 | 2007 | 1309 | 0.030 |
Why?
|
Ascorbic Acid | 1 | 1996 | 654 | 0.030 |
Why?
|
Blood Glucose | 4 | 2008 | 6392 | 0.030 |
Why?
|
Anesthetics, Intravenous | 1 | 2015 | 394 | 0.030 |
Why?
|
Fentanyl | 1 | 2015 | 433 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7865 | 0.030 |
Why?
|
Cerebral Revascularization | 1 | 2015 | 259 | 0.030 |
Why?
|
Transplantation, Autologous | 3 | 2004 | 2112 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2000 | 2208 | 0.020 |
Why?
|
Palpation | 1 | 2012 | 166 | 0.020 |
Why?
|
Infusions, Intravenous | 2 | 2009 | 2217 | 0.020 |
Why?
|
Program Evaluation | 1 | 2020 | 2489 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2024 | 0.020 |
Why?
|
Meglumine | 1 | 2012 | 144 | 0.020 |
Why?
|
Serum Albumin | 2 | 1985 | 674 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1878 | 0.020 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12052 | 0.020 |
Why?
|
Drug-Eluting Stents | 1 | 2017 | 681 | 0.020 |
Why?
|
Kidney | 1 | 2007 | 7033 | 0.020 |
Why?
|
Survival Rate | 1 | 2005 | 12728 | 0.020 |
Why?
|
Renin | 2 | 2007 | 639 | 0.020 |
Why?
|
Gonadal Steroid Hormones | 1 | 1995 | 702 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2016 | 1204 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1812 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 709 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2683 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 1995 | 675 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 874 | 0.020 |
Why?
|
Lipoprotein(a) | 1 | 1995 | 482 | 0.020 |
Why?
|
Double-Blind Method | 3 | 2002 | 12341 | 0.020 |
Why?
|
Phenotype | 1 | 2008 | 16575 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2021 | 2067 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2008 | 36415 | 0.020 |
Why?
|
Life Tables | 2 | 2000 | 364 | 0.020 |
Why?
|
Lamin Type A | 1 | 2010 | 187 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2631 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2114 | 0.020 |
Why?
|
Odds Ratio | 2 | 2016 | 9652 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2021 | 1920 | 0.020 |
Why?
|
Aldosterone | 2 | 2008 | 869 | 0.020 |
Why?
|
Vomiting | 1 | 2012 | 650 | 0.020 |
Why?
|
Preoperative Care | 1 | 2018 | 2241 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 1998 | 2380 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7514 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 823 | 0.020 |
Why?
|
India | 2 | 2006 | 2287 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13511 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2012 | 647 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1916 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23704 | 0.020 |
Why?
|
Delphi Technique | 1 | 2012 | 848 | 0.020 |
Why?
|
Antioxidants | 1 | 1996 | 1667 | 0.020 |
Why?
|
Adaptation, Physiological | 2 | 2008 | 1301 | 0.020 |
Why?
|
Upper Extremity | 1 | 2012 | 658 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 26071 | 0.020 |
Why?
|
Chromatography, Affinity | 2 | 1985 | 525 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2013 | 1067 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6417 | 0.020 |
Why?
|
Catecholamines | 1 | 2008 | 387 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14610 | 0.020 |
Why?
|
Case-Control Studies | 4 | 2009 | 22174 | 0.020 |
Why?
|
Menopause | 1 | 1994 | 1646 | 0.020 |
Why?
|
Renal Circulation | 1 | 2007 | 291 | 0.020 |
Why?
|
Factor X | 1 | 2006 | 64 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2006 | 59 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2009 | 705 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2007 | 672 | 0.020 |
Why?
|
Hemorrhage | 2 | 2009 | 3422 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2008 | 436 | 0.020 |
Why?
|
Growth | 1 | 2008 | 365 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2007 | 12159 | 0.020 |
Why?
|
Young Adult | 2 | 2011 | 59221 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2017 | 4506 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1985 | 1728 | 0.020 |
Why?
|
Administration, Oral | 2 | 2009 | 4015 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2006 | 262 | 0.020 |
Why?
|
Diarrhea | 1 | 2012 | 1316 | 0.020 |
Why?
|
Bone and Bones | 1 | 2016 | 2568 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6486 | 0.020 |
Why?
|
Phenylephrine | 1 | 2006 | 294 | 0.020 |
Why?
|
Cause of Death | 1 | 2016 | 3688 | 0.020 |
Why?
|
Isoelectric Focusing | 1 | 1985 | 149 | 0.020 |
Why?
|
Lipids | 2 | 2007 | 3331 | 0.020 |
Why?
|
Fatigue | 1 | 2012 | 1550 | 0.020 |
Why?
|
Pericardiocentesis | 1 | 2005 | 78 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 2746 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1985 | 641 | 0.010 |
Why?
|
Actinin | 1 | 1985 | 163 | 0.010 |
Why?
|
Pilot Projects | 2 | 2007 | 8642 | 0.010 |
Why?
|
Sodium Chloride | 1 | 2006 | 584 | 0.010 |
Why?
|
Subcutaneous Tissue | 1 | 2004 | 132 | 0.010 |
Why?
|
Animals | 5 | 2024 | 168079 | 0.010 |
Why?
|
Renal Dialysis | 1 | 2013 | 1796 | 0.010 |
Why?
|
Patient Selection | 1 | 2015 | 4246 | 0.010 |
Why?
|
Gravity Suits | 1 | 2002 | 12 | 0.010 |
Why?
|
Albuminuria | 1 | 2007 | 656 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2006 | 908 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2013 | 2220 | 0.010 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2004 | 392 | 0.010 |
Why?
|
Molecular Weight | 1 | 1985 | 2171 | 0.010 |
Why?
|
Sodium | 1 | 2008 | 1589 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 2006 | 655 | 0.010 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2004 | 241 | 0.010 |
Why?
|
Weight Gain | 1 | 2012 | 2349 | 0.010 |
Why?
|
Creatinine | 1 | 2008 | 1897 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2164 | 0.010 |
Why?
|
Rabbits | 2 | 1985 | 4750 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12474 | 0.010 |
Why?
|
Systole | 1 | 2003 | 936 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2002 | 9025 | 0.010 |
Why?
|
Brain | 1 | 2008 | 27092 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13249 | 0.010 |
Why?
|
Artifacts | 1 | 2010 | 1912 | 0.010 |
Why?
|
Diastole | 1 | 2003 | 782 | 0.010 |
Why?
|
Solubility | 1 | 2003 | 1085 | 0.010 |
Why?
|
Bandages | 1 | 2002 | 269 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2009 | 1182 | 0.010 |
Why?
|
Infant | 2 | 2016 | 36169 | 0.010 |
Why?
|
Inguinal Canal | 1 | 2000 | 71 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 1504 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10516 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.010 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2007 | 1039 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2018 | 15637 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8003 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2004 | 877 | 0.010 |
Why?
|
Analysis of Variance | 2 | 1999 | 6223 | 0.010 |
Why?
|
Enzyme Precursors | 1 | 1999 | 167 | 0.010 |
Why?
|
Administration, Intravaginal | 1 | 1999 | 149 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2003 | 1128 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2003 | 1577 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 7966 | 0.010 |
Why?
|
Amino Acids | 1 | 1985 | 1703 | 0.010 |
Why?
|
Adiponectin | 1 | 2004 | 1107 | 0.010 |
Why?
|
Abdomen | 1 | 2004 | 1128 | 0.010 |
Why?
|
Women's Health | 1 | 2008 | 2070 | 0.010 |
Why?
|
Prevalence | 1 | 1995 | 15721 | 0.010 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 1999 | 244 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 1999 | 713 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2007 | 5250 | 0.010 |
Why?
|
Nitroprusside | 1 | 1996 | 272 | 0.010 |
Why?
|
Cold Temperature | 1 | 1999 | 783 | 0.010 |
Why?
|
Heparin | 1 | 2002 | 1632 | 0.010 |
Why?
|
Forecasting | 1 | 2004 | 2928 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29893 | 0.010 |
Why?
|
Radiography | 1 | 2004 | 6974 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2002 | 2075 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2007 | 3417 | 0.010 |
Why?
|
Glucose | 1 | 2003 | 4342 | 0.010 |
Why?
|
Linear Models | 1 | 2000 | 5869 | 0.010 |
Why?
|
Proteins | 1 | 2004 | 5993 | 0.010 |
Why?
|
Body Weight | 1 | 1999 | 4618 | 0.000 |
Why?
|
Regression Analysis | 1 | 1997 | 6345 | 0.000 |
Why?
|
Immunosorbent Techniques | 1 | 1985 | 174 | 0.000 |
Why?
|
Testosterone | 1 | 1995 | 2472 | 0.000 |
Why?
|
Trypsin | 1 | 1985 | 486 | 0.000 |
Why?
|
Cross Reactions | 1 | 1985 | 819 | 0.000 |
Why?
|
Body Mass Index | 1 | 1999 | 12952 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1985 | 13402 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1985 | 5103 | 0.000 |
Why?
|